Literature DB >> 30455839

Risk Stratification of an Accessory Pathway Using Isoproterenol after Cardiac Arrest.

Barry Burstein1, Rodrigo Barbosa1,2, Maude Peretz- Larochelle1, Michelle Samuel1, Vidal Essebag3,4, Martin L Bernier3.   

Abstract

A 43-year-old man presented after ventricular fibrillation cardiac arrest with evidence of pre-excited atrial fibrillation. Electrophysiology study with guideline-directed testing demonstrated a low risk accessory pathway effective refractory period, which became high-risk with isoproterenol infusion. This case represents a challenging scenario wherein a high-risk pathway may be misclassified using the currently indicated methods of risk stratification.

Entities:  

Keywords:  Cardiac Arrest; Electrophysiology study; Risk stratification; Wolff-Parkinson White Syndrome

Year:  2018        PMID: 30455839      PMCID: PMC6207237          DOI: 10.4022/jafib.2054

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  3 in total

1.  2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Richard L Page; José A Joglar; Mary A Caldwell; Hugh Calkins; Jamie B Conti; Barbara J Deal; N A Mark Estes; Michael E Field; Zachary D Goldberger; Stephen C Hammill; Julia H Indik; Bruce D Lindsay; Brian Olshansky; Andrea M Russo; Win-Kuang Shen; Cynthia M Tracy; Sana M Al-Khatib
Journal:  J Am Coll Cardiol       Date:  2015-09-24       Impact factor: 24.094

2.  Wolff-Parkinson-White syndrome and isoproterenol testing in children: a valid adjunct to predict risk?

Authors:  Robert H Pass; Scott R Ceresnak
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-02

3.  Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation.

Authors:  H J Wellens; D Durrer
Journal:  Am J Cardiol       Date:  1974-12       Impact factor: 2.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.